Fibroblast growth factor 21 is elevated in metabolically unhealthy obesity and affects lipid deposition, adipogenesis, and adipokine secretion of human abdominal subcutaneous adipocytes.
about
Cell Models and Their Application for Studying Adipogenic Differentiation in Relation to Obesity: A ReviewImplication of hepatokines in metabolic disorders and cardiovascular diseasesPatterns of Circulating Fibroblast Growth Factor 21 in Subjects with and without Type 2 Diabetes.Single ingestion of soy β-conglycinin induces increased postprandial circulating FGF21 levels exerting beneficial health effects.Recent advances in understanding the role of adipocytokines during non-alcoholic fatty liver disease pathogenesis and their link with hepatokines.Nuclear factor E2-related factor 2 knockdown enhances glucose uptake and alters glucose metabolism in AML12 hepatocytes.The intersection of nonalcoholic fatty liver disease and obesity.Dyslipidemia: Obese or Not Obese-That Is Not the Question.Inter-organ regulation of adipose tissue browning.FGF21 Is Associated with Acanthosis Nigricans in Obese PatientsActivated macrophages control human adipocyte mitochondrial bioenergetics via secreted factorsMuscle mitochondrial stress adaptation operates independently of endogenous FGF21 action.Impact of fibroblast growth factor 21 on the secretome of human perivascular preadipocytes and adipocytes: a targeted proteomics approach.
P2860
Q26744739-11699DE5-E53E-49CE-8E56-FD37F52F5099Q26751147-40089F58-0C13-44CB-8405-83949B3D0EA5Q35833661-BB02C1EC-8D20-4221-A76F-6351DF426EC2Q37014945-4332BB40-54E1-443C-9336-E4DA757F7852Q38665591-93F1D3B1-099D-49AF-ADAE-91D93AF70CBAQ38706187-7A065D12-B71C-4046-A680-643B37FF40F0Q38714560-50705205-DEE8-47B2-892E-FB42D11006ADQ38968519-DD37739E-6758-4881-A433-CBF48494E6ECQ39014497-615B8547-5335-4969-B3CB-DEB991B31C85Q40678883-C0B83F70-2E58-43BA-92EC-FC53326C98ABQ42377885-6FF1EDAA-D881-4D83-A1DA-D5BDEAAA626DQ42541271-7AB38AD9-37CB-4928-B87A-141FDCCBF857Q51592405-10C1B40C-CEA1-4007-92E1-36455F2D4AA1
P2860
Fibroblast growth factor 21 is elevated in metabolically unhealthy obesity and affects lipid deposition, adipogenesis, and adipokine secretion of human abdominal subcutaneous adipocytes.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Fibroblast growth factor 21 is ...... minal subcutaneous adipocytes.
@ast
Fibroblast growth factor 21 is ...... minal subcutaneous adipocytes.
@en
type
label
Fibroblast growth factor 21 is ...... minal subcutaneous adipocytes.
@ast
Fibroblast growth factor 21 is ...... minal subcutaneous adipocytes.
@en
prefLabel
Fibroblast growth factor 21 is ...... minal subcutaneous adipocytes.
@ast
Fibroblast growth factor 21 is ...... minal subcutaneous adipocytes.
@en
P2093
P2860
P50
P1433
P1476
Fibroblast growth factor 21 is ...... minal subcutaneous adipocytes.
@en
P2093
Alfred Königsrainer
Andreas Fritsche
Johannes Beckers
Lucia Berti
Marty Zdichavsky
Tobias Meile
P2860
P304
P356
10.1016/J.MOLMET.2015.04.002
P577
2015-05-01T00:00:00Z